Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. QuVa Pharma, Inc.
483
•QuVa Pharma, Inc.•November 30, 2017

QuVa Pharma, Inc. – FDA 483, Nov 30, 2017

Record Details

This FDA Form 483 document details observations from an inspection, citing deficiencies in sanitation procedures and batch production records. The facility's written procedures for sanitation, specifically SOP NJ-SOP-SA-0003, Section 4.4, were not followed. This SOP requires (b)(4) cleaning of Aseptic Processing Areas (cleanrooms and gowning/ante-rooms) (b)(4) when (b)(4) is used for production activities. However, the (b)(4) cleaning log for ISO-7 cleanroom (b)(4) lacked documentation of cleaning for Heparin 1unit/mL 3L Bulk, Lot (b)(4), which had a compounding date of 10/25/17.

Furthermore, the batch production and control records were found to be deficient. They were not an accurate reproduction of the appropriate master production or control record, nor were they checked for accuracy, dated, and signed as required. These observations indicate issues within the facility's quality system regarding adherence to established sanitation protocols and the integrity of manufacturing documentation. The implications include potential risks to product quality and sterility due to inadequate cleanroom maintenance and a lack of proper record-keeping for production batches.

Company
QuVa Pharma, Inc.
Inspection date
November 30, 2017
Product type
Drugs
Office
New Jersey District Office
People
  • Zakaria I. Ganiyu ( Investigator )
  • Tonia F. Bernard
View Company Profile

ID · db7a8ffe-e43a-4fef-be20-cac0f6d0f13f

Other documents for QuVa Pharma, Inc.
  • 483 - 2022-10-14October 14, 2022
  • WARNING_LETTER - 2022-10-14October 14, 2022
  • 483 - 2022-08-18August 18, 2022
  • 483 - 2019-05-31May 31, 2019
  • 483 - 2019-04-23April 23, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore QuVa Pharma, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.